glp 1 and eyes GLP-1 Meds Reduce Risk of Uveitis GLP-1 Meds Reduce Risk of

The class of drugs, which includes Novo Nordisks Ozempic and Wegovy, are associated with the risk of gastrointestinal adverse events when used for weight loss, finds a study published Thursday in JAMA.

Liquid presentation in an easy-to-use dropper

Ads from Pfizer (for cancer and innovation awareness), Bayer (for heart health), and my personal favorite, Novartis for womens health and promoting the call-to-action for breast cancer screening, added info-tainment to the ad watching see #YourAttentionPlease to track this wonderful health education/literacy promotion for public health

As a budding pharmacist, it is inspiring to see our industry move from "scale" to "solution-driven innovation." Once again, India is proving that true healthcare innovation is measured by how many people it can actually reach